Express Pharma - Page 40 of 2240 - Express Pharma

Government caps margins on cancer medicines at 30%, targets ₹2,500 Cr annual savings

Lupin receives USFDA approval for Phytonadione Injectable Emulsion

Why industry-academia collaboration will shape India’s next R&D chapter

Why ingredient transparency matters more than ever in cosmeceuticals

Indore Pharma Summit: Mapping the future of India pharma

Indore Rising: Central India’s next manufacturing powerhouse

Mr Gajanan Patil, COO, H&H Healthcare and Cosmetics

Panel Discussion: From molecule to market faster: Rethinking drug development

Prof (Dr) Neelesh Malviya, Principal, Smriti College of Pharmaceutical Education, Indore

Mr Vivek Asthana, Head EHS & Sustainability, Symbiotec Pharmalab

Mr Ranjit Menon, Site Head – Indore – Manufacturing, Cipla

Mr Akil Kadiyavala, GM – Technical Services, Dhara Lifescience

Mr Murali Krishna Veeramallu, Head – Industrial Division, Smart Labtech